Biotechnology Market Research Reports

Global Bio-imaging Market By Technology (Magnetic Resonance Imaging (MRI), Computed Tomography (CT), X-ray Imaging, Ultrasound Imaging, Molecular Imaging, Optical Imaging, and Others), Application (Cell Biology, Neuroscience, Developmental Biology, Cancer Research, and Others), End-use (Hospitals and Clinics, Diagnostic Imaging Centers, Research Institutions and Academic Centers, Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), and Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

Report Overview Global Bio-imaging Market size is expected to be worth around US$ 26.37 billion by 2034 from US$ 6.75 billion in 2024, growing at a CAGR of 14.6% during the forecast ...
- ★★★★★
  
  ★★★★★
  
  (142)
- March 2025
- Pages: 321
- US $3,999 Onwards
- Formats:
Global Iron Deficiency Anemia Market By Therapy Type (Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion), By Therapy Area (Obstetrics and Gynecology, Renal Diseases, Congestive Heart Failure (CHF), Oncology, Inflammatory Bowel Disease and Others), By Patient (Adults, Geriatric, Pediatric), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End-User (Hospitals, Specialty Clinics, Home Care Setting and Others) Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

Report Overview Global Iron Deficiency Anemia Market size is expected to be worth around US$ 588.3 million by 2034 from US$ 220.7 million in 2024, growing at a CAGR of 10.3% during t...
- ★★★★★
  
  ★★★★★
  
  (142)
- March 2025
- Pages: 373
- US $3,999 Onwards
- Formats:
Global Lateral Flow Assay Market By Product Type (Kits & Reagents and Lateral Flow Readers (Benchtop Readers and Digital Readers)), By Technology (Sandwich Assays, Competitive Assays, and Multiplex Detection Assays), By Application (Clinical Testing (Infectious Disease Testing (COVID-19 , Mosquito Borne Disease Testing, Influenza Testing, Sexually Transmitted Infection Testing (HIV Testing, HPV Testing, Chlamydia Testing, Gonorrhea Testing, Syphilis Testing, Others), Hepatitis, Tuberculosis, Others), Cardiac Marker Testing (Troponin I and T Testing, CK-MB Testing, BNP and NT-Probnp Testing, Myoglobin Testing, D-Dimer Testing, Others), Pregnancy & Fertility Testing (Pregnancy Testing and Fertility Testing), Cholesterol Testing/Lipid Profile, Drugs of Abuse Testing, Others), Veterinary Diagnostics, Food Safety & Environment Testing, and Drug Development & Quality Testing), By Test Type (Lateral Flow Immunoassay and Nucleic Acid Lateral Flow Assay), By End-User (Hospitals & Clinics, Diagnostic Laboratories, Home Care, Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

Report Overview Global Lateral Flow Assay Market size is expected to be worth around US$ 24.6 billion by 2034 from US$ 16.8 billion in 2024, growing at a CAGR of 3.9% during the fore...
- ★★★★★
  
  ★★★★★
  
  (142)
- March 2025
- Pages: 314
- US $3,999 Onwards
- Formats:
Global Gene Expression Market By Process (Sample Collection, Purification, cDNA Synthesis & Conversion, PCR Analysis, Data Analysis & Interpretation), By Product (Kits & Reagents, DNA Chips, and Others), By Application (Drug Discovery & Development, Clinical Diagnostics, Biotech & Microbiology, and Others), By Technique (RNA Expression, Promoter Analysis, and Protein Expression & Posttranslational Modification Analysis), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

Report Overview The Global Gene Expression Market Size is expected to be worth around US$ 27.5 Billion by 2034, from US$ 15.2 Billion in 2024, growing at a CAGR of 6.1% during the fo...
- ★★★★★
  
  ★★★★★
  
  (142)
- March 2025
- Pages: 264
- US $3,999 Onwards
- Formats:
Global Clinical Oncology Next Generation Sequencing Market By Workflow Type (NGS Sequencing, NGS Pre-Sequencing, and NGS Data Analysis), By Technology (Whole Genome Sequencing, Targeted Sequencing & Resequencing, and Whole Exome Sequencing), By Application (Screening (Sporadic Cancer and Inherited Cancer), Companion Diagnostics, and Others), By End-use (Hospitals & Clinics and Laboratories), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

Report Overview Global Clinical Oncology Next Generation Sequencing Market size is expected to be worth around US$ 3.4 Billion by 2034 from US$ 0.7 Billion in 2024, growing at a CAGR...
- ★★★★★
  
  ★★★★★
  
  (142)
- Feb 2025
- Pages: 373
- US $3,999 Onwards
- Formats:
Monoclonal Antibodies For Cancer Market Product Type (Bevacizumab, Cetumaximab, Ipilimumab, Nivolumab, Pembrolizumab, Pertuzumab, Rituximab, Trastuzumab Trastuzumab and Emtansine), Cancer Type (Breast Cancer, Colorectal Cancer, Lung Cancer, Ovarian Cancer, Blood Cancer, Melanoma, Liver Cancer and Others), Source (Humanized mAb, Human mAb and Chimeric mAb), End-User (Hospitals, Research Institutes and Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

Report Overview The Global Monoclonal Antibodies for Cancer Market size is expected to be worth around US$ 301.4 Billion by 2034, from US$ 78 Billion in 2024, growing at a CAGR of 14...
- ★★★★★
  
  ★★★★★
  
  (142)
- Feb 2025
- Pages: 296
- US $3,999 Onwards
- Formats:

« Previous 1 … 16 17 18 19 20 … 31 Next »